A Day Up For Chimerix, Inc.
Tue, Dec 10, 2024 at 07:06 PM
Chimerix, Inc. (CMRX:NASDAQ) shot up at $2.76, representing a gain of 219.1%. On Tue, Dec 10, 2024, CMRX:NASDAQ touched a New 2-Week High of $2.76. The stock appeared on our News Catalysts scanner on Tue, Dec 10, 2024 at 02:05 PM in the 'BIOTECH' category. From Tue, Nov 26, 2024, the stock recorded 55.56% Up Days and 50.00% Green Days
About Chimerix, Inc. (CMRX:NASDAQ)
Chimerix Inc is a biopharmaceutical company which focuses on the discovery, development, and commercialization of novel, oral antivirals in areas of unmet medical needs.
Top 10 Gainers:
- Chimerix, Inc. (CMRX:NASDAQ), 219.08%
- uniQure N.V. (QURE:NASDAQ), 109.73%
- MSP Recovery Inc. (LIFW:NASDAQ), 103.77%
- Cumberland Pharmaceuticals Inc. (CPIX:NASDAQ), 96.77%
- Roadzen Inc Ord Cl A (RDZN:NASDAQ), 57.58%
- Cardiff Oncology Inc. (CRDF:NASDAQ), 54.92%
- Banzai International, Inc. Class A Common Stock (BNZI:NASDAQ), 47.48%
- SEALSQ Corp. (LAES:NASDAQ), 45.96%
- Falcon's Beyond Global, Inc. (FBYD:NASDAQ), 45.54%
- Rigetti Computing Inc. (RGTI:NASDAQ), 45.19%